ZURA BIO LIMITED Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
ZURA BIO LIMITED (ZURA) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $197.09 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-11
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $197.09M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $216.90M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $101.54M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $109.78M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-06-30 | $197.09M 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $216.90M 10-Q · filed 2026-08-11 | |
| 2025-12-31 | $101.54M 10-Q · filed 2026-08-11 | |
| 2025-09-30 | $109.78M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $127.45M 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $139.74M 10-Q · filed 2026-08-11 | |
| 2024-12-31 | $148.36M 10-Q · filed 2026-08-11 | |
| 2024-09-30 | $154.29M 10-Q · filed 2025-11-13 | $154.59M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $158.06M 10-Q · filed 2025-11-13 | |
| 2024-03-31 | $62.55M 10-Q · filed 2025-08-14 | |
| 2023-12-31 | $60.87M 10-K · filed 2026-03-19 | |
| 2023-09-30 | $64.75M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $70.45M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $27.86M 10-Q · filed 2024-08-13 | |
| 2022-12-31 | -$32.06M 10-K · filed 2025-03-25 | |
| 2022-09-30 | -$9.53M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | -$8.44M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | -$7.82M 10-Q · filed 2023-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| AGENUS INC (AGEN) | United States | $0.383B | 1.41 |
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |